bs-6675R [Primary Antibody]
KCNN4 Polyclonal Antibody
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: KCNN4

Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 3783

Swiss Prot: O15554

Source: KLH conjugated synthetic peptide derived from human KCNN4

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.

Size: 100µL

Concentration: 1mg/ml

Applications: WB(WB=1:500-2000)
ELISA(ELISA=1:5000-10000)

Predicted Molecular Weight: 50


Cross Reactive Species: Human
Mouse

Predicted Cross Reactive Species: Rat

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Zhang, Panshi, et al. "Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells." PLOS ONE 11.4 (2016): e0154471.Read more>>
  • Lively et al. Comparing Effects of Transforming Growth Factor β1 on Microglia From Rat and Mouse: Transcriptional Profiles and Potassium Channels. (2018) Front.Cell.Neurosci. 12:115Read more>>
  • Liu Dishiwen. et al. Cardiac Fibroblasts Promote Ferroptosis in Atrial Fibrillation by Secreting Exo-miR-23a-3p Targeting SLC7A11. OXID MED CELL LONGEV. 2022;2022:3961495Read more>>
VALIDATION IMAGES

Lane 1: rat brain lysates Lane 2: rat heart lysates probed with Anti KCNN4 Polyclonal Antibody, Unconjugated (bs-6675R) at 1:200 in 4˚C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:3000 90min in RT. Predicted band 50kD. Observed band size: 45kD, 50kD.


Lane 1: Human U-2 OS cell lysates; Lane 2: Human U87MG cell lysates; Lane 3: Human HeLa cell lysates; Lane 4: Human U251 cell lysates; Lane 5: Human LOVO cell lysates; Lane 6: Human HepG2 cell lysates probed with KCNN4 Polyclonal Antibody, Unconjugated (bs-6675R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at room temperature for 60 min.